Back to results
Bibliographic record · Consultation and access
Artículo

Predicting outcomes in hyperthyroid cats treated with radioiodine

Mark E. Peterson et al · Oxford University Press · 2022

Supplementary material available
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.
Serial publication

A de novo nonsense variant in the DMD gene associated with X‐linked dystrophin‐deficient muscular dystrophy in a cat

This serial publication contains 149 related contents.

Resource access

Open the content from the main option or choose another available source.

DOAJ DOAJ Articles
Entrar por DOAJ
Main access

Supplementary material available

El enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Open material

Summary

Descripción general del contenido del recurso.

Abstract Background Radioiodine (131I) is the treatment of choice for cats with hyperthyroidism. After 131I, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. Objectives To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel 131I dosing algorithm. Animals One thousand and four hundred hyperthyroid cats treated with 131I. Methods Prospective, before‐and‐after study. Pretreatment predictors (clinical, laboratory, scintigraphic, 131I dose, 131I uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. Results Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04‐1.17; P = .001), female (OR = 2.04; 95% CI, 1.54‐2.70; P < .001), have detectable serum thyroid‐stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0‐8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19‐2.08; P < .001), have homogeneous, bilateral distribution of 99mTc‐pertechnetate uptake (OR = 2.93; 95% CI, 2.05‐4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49‐0.79; P < .001), and have higher 131I uptake (OR = 2.40; 95% CI, 1.75‐3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72‐0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51‐2.31; P < .001), and have lower 131I uptake (OR = 3.50; 95% CI, 1.8‐6.80; P < .001). Conclusions and Clinical Importance Age, sex, serum TSH concentration, bilateral and homogeneous 99mTc‐pertechnetate uptake on scintigraphy, severity score, and percent 131I uptake are all factors that might help predict outcome of 131I treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed 131I‐induced hypothyroidism.

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, M. E. P. E. (2022). Predicting outcomes in hyperthyroid cats treated with radioiodine. https://doi.org/10.1111/jvim.16319

MLA

al, Mark E. Peterson et. "Predicting outcomes in hyperthyroid cats treated with radioiodine." 2022. https://doi.org/10.1111/jvim.16319.

Chicago

al, Mark E. Peterson et. 2022. "Predicting outcomes in hyperthyroid cats treated with radioiodine.". https://doi.org/10.1111/jvim.16319.

Harvard

al, M. E. P. E. 2022, Predicting outcomes in hyperthyroid cats treated with radioiodine, Oxford University Press, available at: https://doi.org/10.1111/jvim.16319 [Accessed 5 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
Predicting outcomes in hyperthyroid cats treated with radioiodine
Author / contributors
Mark E. Peterson et al
Publisher
Oxford University Press
Publication year
2022
ISSN
0891-6640
ISSN
0891-6640
Language
English

Subjects

Explore related resources through these subjects.

Copied